Welcoming New Faculty – Omar Selim, MD, MSC, FRCSC, RPVI

Please join us in welcoming Dr. Selim as a new faculty member in the Department of Surgery.

Omar Selim, MD, MSC, FRCSC, RPVI
Associate Surgeon, Division of Vascular and Endovascular Surgery

Dr. Selim completed his undergraduate studies at Dalhousie University in Halifax, Nova Scotia, Canada, and received his medical degree from McMaster University in Ontario, Canada. He holds a Master of Science in medical education from the University of Toronto, where he also completed an integrated residency in vascular surgery. He completed research fellowships at the Temerty-Chang Telesimulation Centre and the Wilson Centre Health Professions Education Research program, both in Toronto.

Before joining the Brigham, Dr. Selim was an assistant professor of vascular surgery at Tufts Medical Center and Tufts University School of Medicine. Prior to this, he was a vascular surgeon at a private practice in Ontario, Canada.

Dr. Selim’s clinical interests include complex open and endovascular aortic surgery, peripheral arterial disease, cerebrovascular disease and dialysis access, as well as the full spectrum of vascular disease.

His research interests are primarily within the field of quantitative medical education research, with a particular interest in simulation, assessment practice, and generalizability and validity theory. He also has a strong interest in vascular and endovascular device trials.

Ali Tavakkoli, MD, Named the Francis Daniels Moore Associate Professor of Surgery at Harvard Medical School

Ali Tavakkoli, MD
Chief, Division of General and Gastrointestinal Surgery
Co-Director, Center for Weight Management and Wellness
Program Director, Advanced Minimally Invasive Fellowship
Francis Daniels Moore Associate Professor of Surgery, Harvard Medical School

Dr. Tavakkoli is a minimally invasive and bariatric surgeon at Brigham and Women’s Hospital, where he serves as the chief of the Division of General and GI Surgery, co-director of the Center for Weight Management and Wellness and director of the minimally invasive surgery fellowship. He is an associate professor of surgery at Harvard Medical School.

He received his medical degree from London Hospital Medical College in the UK and became a fellow of the Royal College of Surgeons of England before moving to Boston, where he completed both a surgical residency and fellowship in advanced minimally invasive surgery at the Brigham.

Dr. Tavakkoli leads an active NIH-funded research group that studies the mechanisms of diabetes resolution after gastric bypass surgery, focusing on the role of intestinal metabolism and portal signaling. His group’s goals are to develop less invasive alternatives to surgery that can replicate the metabolic benefits of surgery without the risks.

He is an active member of many professional societies, including serving as a member of the Board of Governors of the American College of Surgeons, president of the Massachusetts Chapter of the American College of Surgeons, Recorder for the New England Surgical Society, and Board of Directors of the Fellowship Council.  He served as an associate editor for the journal of Digestive Disease and Sciences for over a decade and is on the editorial board of the Journal of Gastrointestinal Surgery.  He has been recognized for his dedication to surgical education with several teaching and mentorship awards throughout his career.

Chandrajit P. Raut, MD, MSc, Named the Richard E. Wilson Professor of Surgery in the Field of Surgical Oncology at Harvard Medical School

Chandrajit P. Raut, MD, MSc
Chief, Division of Surgical Oncology, Brigham and Women’s Hospital
BWH Distinguished Chair in Surgical Oncology, Brigham and Women’s Hospital
Chair of Surgery, Dana-Farber Cancer Institute
Director, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute
Richard E. Wilson Professor of Surgery in the Field of Surgical Oncology, Harvard Medical School

Dr. Raut is a committed clinician who specializes in the multidisciplinary care of patients with soft tissue sarcoma. He is also a prolific researcher and has a multi-PI R01 grant to evaluate an innovative drug-eluting film to be placed in the surgical bed and reduce tumor local recurrence rates. Additionally, he was co-PI on a multi-institutional phase II clinical trial evaluating five years of adjuvant imatinib for primary gastrointestinal stromal tumor (GIST), co-investigator on an international phase III randomized clinical trial evaluating the use of preoperative radiation therapy for retroperitoneal sarcomas and a member of The Cancer Genome Atlas Sarcoma (TCGA-SARC) working group of the National Institutes of Health (NIH)/National Cancer Institute (NCI).

Dr. Raut serves as section editor for sarcoma in the journals Cancer and Annals of Surgical Oncology, associate editor for the journal Sarcoma and editorial board member for the journal ACS Case Reports in Surgery. He has authored over 210 papers and over 30 book chapters.

Dr. Raut is a graduate of Stanford University (BA/BS), University of Oxford (MSc) and Harvard Medical School (MD). He completed a residency in general surgery at Massachusetts General Hospital followed by a fellowship in surgical oncology at MD Anderson Cancer Center.